Obstet Gynaecol Reprod Med 28:714
Regardless of the GLP-1 RA users taking the drug for the purpose of treating diabetes or for weight loss reasons, this statistic still varied considerably between 15%56% in GLP-1 RA users compared to 5%20% in controls not taking the drug (Chang et al
The reasons fall into several distinct categories, and your specific reason shapes which alternative makes the most sense
Decisions should be made collaboratively between oncology, endocrinology, and primary care, with clear documentation of the risk-benefit discussion and informed patient consent
Ashley Brissette, an ophthalmologist in New York City, told Fox News Digital that NAION is an "extremely rare" but serious medical condition
These contraindications are not suggestions